JP2019518739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019518739A5 JP2019518739A5 JP2018559785A JP2018559785A JP2019518739A5 JP 2019518739 A5 JP2019518739 A5 JP 2019518739A5 JP 2018559785 A JP2018559785 A JP 2018559785A JP 2018559785 A JP2018559785 A JP 2018559785A JP 2019518739 A5 JP2019518739 A5 JP 2019518739A5
- Authority
- JP
- Japan
- Prior art keywords
- liposome
- lipid
- peg
- mol
- pegylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002502 liposome Substances 0.000 claims 23
- 150000002632 lipids Chemical class 0.000 claims 20
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 8
- 239000000556 agonist Substances 0.000 claims 7
- 102000002689 Toll-like receptor Human genes 0.000 claims 6
- 108020000411 Toll-like receptor Proteins 0.000 claims 6
- 230000028993 immune response Effects 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 230000007935 neutral effect Effects 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 235000012000 cholesterol Nutrition 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 claims 2
- FVXDQWZBHIXIEJ-LNDKUQBDSA-N 1,2-di-[(9Z,12Z)-octadecadienoyl]-sn-glycero-3-phosphocholine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC FVXDQWZBHIXIEJ-LNDKUQBDSA-N 0.000 claims 2
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 claims 2
- SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 claims 2
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 claims 2
- GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 2
- 230000004044 response Effects 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims 1
- LVNGJLRDBYCPGB-LDLOPFEMSA-N (R)-1,2-distearoylphosphatidylethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC LVNGJLRDBYCPGB-LDLOPFEMSA-N 0.000 claims 1
- FBFJOZZTIXSPPR-UHFFFAOYSA-N 1-(4-aminobutyl)-2-(ethoxymethyl)imidazo[4,5-c]quinolin-4-amine Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CCCCN)C3=C(N)N=C21 FBFJOZZTIXSPPR-UHFFFAOYSA-N 0.000 claims 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims 1
- 229940124613 TLR 7/8 agonist Drugs 0.000 claims 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims 1
- 102100039360 Toll-like receptor 4 Human genes 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000015788 innate immune response Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 239000007764 o/w emulsion Substances 0.000 claims 1
- 150000008105 phosphatidylcholines Chemical class 0.000 claims 1
- 229940031439 squalene Drugs 0.000 claims 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 0 CCC(*C(C(C)C(*NC(C)=CC)OC*)[C@@](C)C(C)C)=C Chemical compound CCC(*C(C(C)C(*NC(C)=CC)OC*)[C@@](C)C(C)C)=C 0.000 description 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022143788A JP2022177112A (ja) | 2016-05-16 | 2022-09-09 | Ｐｅｇ化リポソームおよび使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662337328P | 2016-05-16 | 2016-05-16 | |
| US62/337,328 | 2016-05-16 | ||
| PCT/US2017/032756 WO2017200957A1 (en) | 2016-05-16 | 2017-05-15 | Pegylated liposomes and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143788A Division JP2022177112A (ja) | 2016-05-16 | 2022-09-09 | Ｐｅｇ化リポソームおよび使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019518739A JP2019518739A (ja) | 2019-07-04 |
| JP2019518739A5 true JP2019518739A5 (cg-RX-API-DMAC7.html) | 2020-06-25 |
| JP7195147B2 JP7195147B2 (ja) | 2022-12-23 |
Family
ID=58794159
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559785A Active JP7195147B2 (ja) | 2016-05-16 | 2017-05-15 | Ｐｅｇ化リポソームおよび使用方法 |
| JP2022143788A Pending JP2022177112A (ja) | 2016-05-16 | 2022-09-09 | Ｐｅｇ化リポソームおよび使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143788A Pending JP2022177112A (ja) | 2016-05-16 | 2022-09-09 | Ｐｅｇ化リポソームおよび使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11266602B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3458028A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7195147B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102483033B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109562057A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017268175B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112018073676B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3023672A1 (cg-RX-API-DMAC7.html) |
| IL (3) | IL319503A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2018013640A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017200957A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201807128B (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11266602B2 (en) | 2016-05-16 | 2022-03-08 | Infectious Disease Research Institute | PEGylated liposomes and methods of use |
| CN107998070A (zh) * | 2017-12-12 | 2018-05-08 | 南京中医药大学 | 一种复合磷脂传递体及其在制备经皮给药制剂中的应用 |
| WO2020109365A1 (en) * | 2018-11-29 | 2020-06-04 | Glaxosmithkline Biologicals Sa | Methods for manufacturing an adjuvant |
| AU2019400340A1 (en) * | 2018-12-17 | 2021-05-20 | Eisai R&D Management Co., Ltd. | Formulation comprising liposomes |
| CN110151702A (zh) * | 2019-06-24 | 2019-08-23 | 昆明医科大学 | 聚乙二醇修饰流感疫苗脂质体及其制备方法 |
| US11679163B2 (en) | 2019-09-20 | 2023-06-20 | Hdt Bio Corp. | Compositions and methods for delivery of RNA |
| KR102328531B1 (ko) * | 2020-01-23 | 2021-11-17 | 서울대학교산학협력단 | 체내 면역 세포 표적 황화수소 공여체 담지 리포좀을 포함하는 면역질환 치료 또는 예방용 약학 조성물 |
| GB2605312B (en) | 2020-03-23 | 2024-06-26 | Hdt Bio Corp | Compositions and methods for delivery of RNA |
| CA3186799A1 (en) * | 2020-07-22 | 2022-01-27 | Navin VARADARAJAN | Treatment and prevention of conditions associated with respiratory diseases |
| CN117120087A (zh) | 2020-12-23 | 2023-11-24 | 高级健康研究所 | 茄尼醇疫苗助剂及其制备方法 |
| US20240180834A1 (en) * | 2021-02-26 | 2024-06-06 | Univesity Of Virginia Patent Foundation | Development of covid-19 vaccine using a dual tlr ligand liposome adjuvant |
| EP4304567A1 (en) * | 2021-03-11 | 2024-01-17 | The Trustees of the University of Pennsylvania | Targeted therapeutic lipid nanoparticles and methods of use |
| KR102682082B1 (ko) * | 2021-06-01 | 2024-07-05 | 서울대학교산학협력단 | 리포좀 및 이를 포함하는 암 방사선 치료용 약학 조성물 |
| JP2024535354A (ja) | 2021-09-22 | 2024-09-30 | エイチディーティー バイオ コーポレーション | がん治療組成物およびその使用 |
| JP2024535351A (ja) | 2021-09-22 | 2024-09-30 | エイチディーティー バイオ コーポレーション | 乾燥ナノ粒子組成物 |
| AU2022351009A1 (en) | 2021-09-22 | 2024-04-11 | Hdt Bio Corp. | Rna vaccines against infectious diseases |
| AU2022349251A1 (en) | 2021-09-22 | 2024-04-11 | Hdt Bio Corp. | Sars-cov-2 rna vaccine compositions and methods of use |
| EP4637712A1 (en) * | 2022-12-19 | 2025-10-29 | Newimmune II, LLC | Nanoparticulate formulation |
| CN115737800B (zh) * | 2023-01-09 | 2023-05-23 | 江苏瑞科生物技术股份有限公司 | 一种复合脂质体佐剂及其制备方法 |
| WO2025245466A1 (en) * | 2024-05-24 | 2025-11-27 | Curevo, Inc. | Immunogenic compositions for the prevention of herpes zoster |
Family Cites Families (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3598122A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US4286592A (en) | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
| US4314557A (en) | 1980-05-19 | 1982-02-09 | Alza Corporation | Dissolution controlled active agent dispenser |
| US4379454A (en) | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| IL73534A (en) | 1983-11-18 | 1990-12-23 | Riker Laboratories Inc | 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds |
| US4568343A (en) | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| FI861417A0 (fi) | 1985-04-15 | 1986-04-01 | Endotronics Inc | Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav. |
| US4948587A (en) | 1986-07-08 | 1990-08-14 | Massachusetts Institute Of Technology | Ultrasound enhancement of transbuccal drug delivery |
| US4767402A (en) | 1986-07-08 | 1988-08-30 | Massachusetts Institute Of Technology | Ultrasound enhancement of transdermal drug delivery |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| EP0304578B1 (en) | 1987-06-22 | 2001-10-24 | Medeva Holdings Bv | Peptide comprising hepatitis B surface antigen |
| US4780212A (en) | 1987-07-31 | 1988-10-25 | Massachusetts Institute Of Technology | Ultrasound enchancement of membrane permeability |
| US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| GB2232892B (en) | 1988-02-23 | 1991-07-24 | John Mark Tucker | Occlusive body for administering a physiologically active substance |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| GB8819209D0 (en) | 1988-08-12 | 1988-09-14 | Research Corp Ltd | Polypeptide & dna encoding same |
| US4999403A (en) | 1988-10-28 | 1991-03-12 | Exxon Chemical Patents Inc. | Graft polymers of functionalized ethylene-alpha-olefin copolymer with polypropylene, methods of preparation, and use in polypropylene compositions |
| MC2178A1 (fr) | 1988-12-16 | 1992-05-22 | Nederlanden Staat | Mutants de la pneumolysine et vaccins a base de pneumocoque prepares a partir de ces mutants |
| ATE159031T1 (de) | 1989-07-25 | 1997-10-15 | Smithkline Biolog | Antigene sowie verfahren zu deren herstellung |
| US5256643A (en) | 1990-05-29 | 1993-10-26 | The Government Of The United States | Human cripto protein |
| GB9106048D0 (en) | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccines |
| DK0595935T3 (da) | 1991-07-19 | 2003-07-21 | Csl Ltd | Papillomavirusvaccine |
| US5464387A (en) | 1991-07-24 | 1995-11-07 | Alza Corporation | Transdermal delivery device |
| KR100251505B1 (ko) | 1991-11-16 | 2000-05-01 | 장 스테판느 | 말라리아원충으로부터의 cs 및 hbsag 사이의 혼성 단백질(hybrid protein between cs from plasmodium and hbsag) |
| DE122007000098I1 (de) | 1992-06-25 | 2008-03-27 | Papillomavirus vakzine | |
| US5786148A (en) | 1996-11-05 | 1998-07-28 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a novel prostate-specific kallikrein |
| US5437951A (en) | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
| PT688227E (pt) | 1993-03-09 | 2005-10-31 | Univ Rochester | Producao de proteina da capsula de papiloma humano e particulas semelhantes a virus |
| WO1995002597A1 (en) | 1993-07-15 | 1995-01-26 | Minnesota Mining And Manufacturing Company | IMIDAZO[4,5-c]PYRIDIN-4-AMINES |
| EP0892446B1 (en) | 1993-11-02 | 2006-05-24 | Matsushita Electric Industrial Co., Ltd. | Method of manufacturing an aggregate of semiconductor micro-needles and method of manufacturing a semiconductor device comprising an aggregate of semiconductor micro-needles |
| US5814599A (en) | 1995-08-04 | 1998-09-29 | Massachusetts Insitiute Of Technology | Transdermal delivery of encapsulated drugs |
| US5885211A (en) | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
| US5458140A (en) | 1993-11-15 | 1995-10-17 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
| US5688506A (en) | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
| US5457041A (en) | 1994-03-25 | 1995-10-10 | Science Applications International Corporation | Needle array and method of introducing biological substances into living cells using the needle array |
| US5591139A (en) | 1994-06-06 | 1997-01-07 | The Regents Of The University Of California | IC-processed microneedles |
| AU4270196A (en) | 1994-10-07 | 1996-05-02 | Lutz Gissmann | Papilloma virus-like particles, fusion proteins and process for producing the same |
| US5955087A (en) | 1995-02-24 | 1999-09-21 | Cantab Pharmaceuticals Research Limited | Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
| US5843464A (en) | 1995-06-02 | 1998-12-01 | The Ohio State University | Synthetic chimeric fimbrin peptides |
| US5981215A (en) | 1995-06-06 | 1999-11-09 | Human Genome Sciences, Inc. | Human criptin growth factor |
| US5618275A (en) | 1995-10-27 | 1997-04-08 | Sonex International Corporation | Ultrasonic method and apparatus for cosmetic and dermatological applications |
| US5656016A (en) | 1996-03-18 | 1997-08-12 | Abbott Laboratories | Sonophoretic drug delivery system |
| US5955306A (en) | 1996-09-17 | 1999-09-21 | Millenium Pharmaceuticals, Inc. | Genes encoding proteins that interact with the tub protein |
| US7033598B2 (en) | 1996-11-19 | 2006-04-25 | Intrabrain International N.V. | Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal |
| US5840871A (en) | 1997-01-29 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Prostate-associated kallikrein |
| DK0972201T3 (da) | 1997-02-25 | 2006-01-02 | Corixa Corp | Forbindelser til immundiagnosticering af prostatacancer og fremgangsmåder til anvendelse heraf |
| KR100619350B1 (ko) | 1997-07-21 | 2006-09-05 | 박스터 헬쓰케어 에스.에이. | 변형 면역성 뉴멀리신 백신조성물 |
| GB9717953D0 (en) | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| US7459524B1 (en) | 1997-10-02 | 2008-12-02 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, sequence and uses thereof |
| JP2002517179A (ja) | 1997-11-28 | 2002-06-18 | ジェンセット | Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓゲノム配列およびポリペプチド、それらのフラグメント、ならびに特に感染症の診断、予防および治療のためのそれらの使用 |
| UA67760C2 (uk) | 1997-12-11 | 2004-07-15 | Міннесота Майнінг Енд Мануфакчурінг Компані | Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки |
| CN1227360C (zh) | 1998-02-05 | 2005-11-16 | 史密丝克莱恩比彻姆生物有限公司 | Mage家族肿瘤相关抗原衍生物及其编码核酸序列 |
| CN1629185B (zh) | 1998-04-07 | 2011-11-02 | 科里克萨公司 | 结核杆菌抗原融合蛋白及其应用 |
| GB2336310B (en) | 1998-04-14 | 2003-09-10 | Stowic Resources Ltd | Method of manufacturing transdermal patches |
| AU3560399A (en) | 1998-04-15 | 1999-11-01 | Ludwig Institute For Cancer Research | Tumor associated nucleic acids and uses therefor |
| US6322532B1 (en) | 1998-06-24 | 2001-11-27 | 3M Innovative Properties Company | Sonophoresis method and apparatus |
| KR20010083111A (ko) | 1998-07-14 | 2001-08-31 | 길리스 스티브 | 전립선암의 치료 및 진단을 위한 조성물 및 방법 |
| US6110929A (en) | 1998-07-28 | 2000-08-29 | 3M Innovative Properties Company | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| DK1187629T3 (da) | 1999-04-19 | 2005-01-17 | Glaxosmithkline Biolog Sa | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid |
| US6685699B1 (en) | 1999-06-09 | 2004-02-03 | Spectrx, Inc. | Self-removing energy absorbing structure for thermal tissue ablation |
| JP4162813B2 (ja) | 1999-10-28 | 2008-10-08 | 久光製薬株式会社 | イオントフォレーシス装置 |
| US6974588B1 (en) | 1999-12-07 | 2005-12-13 | Elan Pharma International Limited | Transdermal patch for delivering volatile liquid drugs |
| US6908453B2 (en) | 2002-01-15 | 2005-06-21 | 3M Innovative Properties Company | Microneedle devices and methods of manufacture |
| US6676961B1 (en) | 2002-03-06 | 2004-01-13 | Automated Carrier Technologies, Inc. | Transdermal patch assembly |
| US7018345B2 (en) | 2002-12-06 | 2006-03-28 | Hisamitsu Pharmaceutical Co., Inc. | Iontophoresis system |
| KR20060120069A (ko) | 2003-10-03 | 2006-11-24 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 피라졸로피리딘 및 그의 유사체 |
| DE102005032175A1 (de) | 2005-07-09 | 2007-01-18 | Krones Ag | Behälter-Behandlungsmaschine und Verfahren zum Laden und Entladen einer Behälter-Behandlungsmaschine |
| ATE383895T1 (de) | 2005-07-19 | 2008-02-15 | Holzapfel Gmbh & Co Kg Geb | Auftriebshilfe |
| US9333250B2 (en) * | 2006-04-06 | 2016-05-10 | The Johns Hopkins University | Methods and compositions for treating bacterial infection |
| SI2468300T1 (en) * | 2006-09-26 | 2018-03-30 | Infectios Disease Research Institute | A vaccine composition comprising a synthetic adjuvant |
| SI2510946T1 (sl) * | 2007-02-07 | 2015-12-31 | The Regents Of The University Of California | Konjugati sintetičnih agonistov TLR in njihove uporabe |
| PL2136836T3 (pl) | 2007-04-04 | 2017-07-31 | Infectious Disease Research Institute | Kompozycje immunogenne zawierające polipeptydy prątka gruźlicy i produkty ich fuzji |
| US8793881B2 (en) | 2008-08-15 | 2014-08-05 | Stanley Black & Decker, Inc. | Utility knife with blade lock |
| KR20110050531A (ko) * | 2008-08-28 | 2011-05-13 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| PE20110992A1 (es) * | 2009-02-17 | 2012-02-12 | Glaxosmithkline Biolog Sa | Composicion inmunogenica que comprende un antigeno del virus del dengue |
| BRPI1011072B1 (pt) | 2009-06-05 | 2021-09-28 | Infectious Disease Research Institute | Composto de gla, composições de vacina e farmacêutica compreendendo dito composto, bem como uso dos mesmos para estimular, induzir ou acentuar uma resposta imune em um indivíduo |
| WO2010143971A2 (en) * | 2009-06-08 | 2010-12-16 | Epitarget As | Lipophilic drug carrier |
| TWI397428B (zh) * | 2009-12-29 | 2013-06-01 | Ind Tech Res Inst | 標的第四介白素受體之傳輸系統 |
| US20120014866A1 (en) | 2010-07-15 | 2012-01-19 | Ivor Bull | Copper Containing ZSM-34, OFF And/Or ERI Zeolitic Material For Selective Reduction Of NOx |
| CN105294684B (zh) | 2010-08-17 | 2018-04-06 | 3M创新有限公司 | 脂质化免疫反应调节剂化合物的组合物、制剂及方法 |
| SI3970742T1 (sl) * | 2010-08-31 | 2022-08-31 | Glaxosmithkline Biologicals S.A. | Pegilirani liposomi za dostavo RNA, ki kodira imunogen |
| IN2014CN02581A (cg-RX-API-DMAC7.html) * | 2011-10-06 | 2015-08-07 | Immunovaccine Technologies Inc | |
| EP3424564A1 (en) | 2011-10-31 | 2019-01-09 | Mallinckrodt LLC | Combinational liposome compositions for cancer therapy |
| EP2787977A4 (en) * | 2011-12-09 | 2015-05-06 | Univ California | LIPOSOMAL ACTIVE INVERTING |
| WO2013119856A1 (en) * | 2012-02-07 | 2013-08-15 | Infectious Disease Research Institute | Improved adjuvant formulations comprising tlr4 agonists and methods of using the same |
| CA2869748C (en) * | 2012-04-12 | 2017-10-24 | Yale University | Vehicles for controlled delivery of different pharmaceutical agents |
| WO2013188699A1 (en) | 2012-06-13 | 2013-12-19 | Incytu, Inc. | Compositions, methods and devices for activating an immune response |
| WO2014008406A2 (en) * | 2012-07-05 | 2014-01-09 | Children's Medical Center Corporation | The bacterial biofilm matrix as a platform for protein delivery |
| WO2014018737A1 (en) | 2012-07-26 | 2014-01-30 | National Oilwell Varco L.P. | Telescoping core barrel |
| US8638146B1 (en) | 2012-07-31 | 2014-01-28 | Cambridge Silicon Radio Limited | Dual mode phase detection |
| EP2968142A1 (en) * | 2013-03-13 | 2016-01-20 | Mallinckrodt LLC | Liposomal cisplatin compositions for cancer therapy |
| WO2015123496A1 (en) * | 2014-02-14 | 2015-08-20 | Immune Design Corp. | Immunotherapy of cancer through combination of local and systemic immune stimulation |
| WO2015136479A1 (en) * | 2014-03-12 | 2015-09-17 | Glaxosmithkline Biologicals S.A. | Liposomal compositions for mucosal delivery |
| CN105534908B (zh) * | 2016-01-15 | 2018-12-14 | 徐州医学院 | 一种包载核酸药物的具缺氧响应能力和放疗增敏功能脂质体 |
| US11266602B2 (en) | 2016-05-16 | 2022-03-08 | Infectious Disease Research Institute | PEGylated liposomes and methods of use |
-
2017
- 2017-05-15 US US16/098,619 patent/US11266602B2/en active Active
- 2017-05-15 IL IL319503A patent/IL319503A/en unknown
- 2017-05-15 EP EP17726411.6A patent/EP3458028A1/en not_active Withdrawn
- 2017-05-15 BR BR112018073676-7A patent/BR112018073676B1/pt active IP Right Grant
- 2017-05-15 AU AU2017268175A patent/AU2017268175B2/en active Active
- 2017-05-15 CA CA3023672A patent/CA3023672A1/en active Pending
- 2017-05-15 WO PCT/US2017/032756 patent/WO2017200957A1/en not_active Ceased
- 2017-05-15 MX MX2018013640A patent/MX2018013640A/es unknown
- 2017-05-15 IL IL313085A patent/IL313085B2/en unknown
- 2017-05-15 JP JP2018559785A patent/JP7195147B2/ja active Active
- 2017-05-15 IL IL263030A patent/IL263030B2/en unknown
- 2017-05-15 CN CN201780030294.4A patent/CN109562057A/zh active Pending
- 2017-05-15 KR KR1020187034749A patent/KR102483033B1/ko active Active
-
2018
- 2018-10-25 ZA ZA2018/07128A patent/ZA201807128B/en unknown
-
2021
- 2021-12-23 US US17/560,594 patent/US12318484B2/en active Active
-
2022
- 2022-09-09 JP JP2022143788A patent/JP2022177112A/ja active Pending
-
2023
- 2023-02-01 AU AU2023200515A patent/AU2023200515B2/en active Active
-
2025
- 2025-01-17 US US19/027,710 patent/US20250241857A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019518739A5 (cg-RX-API-DMAC7.html) | ||
| Tretiakova et al. | Liposomes as adjuvants and vaccine delivery systems | |
| Pedersen et al. | Immunocorrelates of CAF family adjuvants | |
| Tandrup Schmidt et al. | Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators | |
| Marasini et al. | Liposomes as a vaccine delivery system | |
| Davidsen et al. | Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6, 6′-dibehenate)—a novel adjuvant inducing both strong CMI and antibody responses | |
| Felnerova et al. | Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs | |
| Kersten et al. | Liposomes and ISCOMS | |
| Giddam et al. | Liposome-based delivery system for vaccine candidates: constructing an effective formulation | |
| EP3964200A1 (en) | Compositions and methods for delivery of therapeutic agents | |
| JP6703982B2 (ja) | 脂質およびリポソームの安定な製剤 | |
| CN103476431B (zh) | 包含阳离子脂质的用于带负电荷的药物的载体及其制备方法 | |
| Nordly et al. | Immunity by formulation design: induction of high CD8+ T-cell responses by poly (I: C) incorporated into the CAF01 adjuvant via a double emulsion method | |
| Obeid et al. | Examination of the effect of niosome preparation methods in encapsulating model antigens on the vesicle characteristics and their ability to induce immune responses | |
| Liu et al. | A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice | |
| US4117113A (en) | Immunological preparations | |
| FR2726764A1 (fr) | Adjuvant pour composition vaccinale | |
| JP2012532200A5 (cg-RX-API-DMAC7.html) | ||
| CN115335084A (zh) | 包含聚肌氨酸的rna颗粒 | |
| JP2020526530A5 (cg-RX-API-DMAC7.html) | ||
| KR20160132088A (ko) | 점막 전달용 리포솜 조성물 | |
| Soni et al. | The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems | |
| WO2024209013A1 (en) | Lipid nanoparticle compositions | |
| Nielsen et al. | ISCOMs as a vaccine delivery system | |
| JP2023500921A (ja) | 免疫誘導用ポリマーナノ粒子組成物及びその製造方法 |